This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Saheli Chowdhury: Innovator in Non-Alcoholic Fatty Liver Disease Treatment
Introduction
Saheli Chowdhury is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of medical research, particularly in the treatment of non-alcoholic fatty liver disease (NAFLD). Her innovative work has garnered attention for its potential impact on health and wellness.
Latest Patents
Saheli Chowdhury holds a patent for "Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof." This patent includes compounds that inhibit or modulate the Ubiquitin Ligase COP1 enzyme, which can produce a physiologically beneficial response. The compounds are designed to increase the level of adipose triglyceride lipase (ATGL), offering a promising avenue for treating NAFLD. She has 1 patent to her name.
Career Highlights
Saheli Chowdhury is affiliated with the Council of Scientific and Industrial Research, where she conducts her research and development. Her work is characterized by a commitment to advancing medical science and improving treatment options for liver diseases.
Collaborations
Some of her notable coworkers include Arindam Talukdar and Partha Chakrabarti. Their collaborative efforts contribute to the innovative research environment at the Council of Scientific and Industrial Research.
Conclusion
Saheli Chowdhury's contributions to the treatment of non-alcoholic fatty liver disease highlight her role as a leading inventor in the medical field. Her innovative research and dedication to improving health outcomes are commendable.